Rallybio Leverages Founders’ Experience, $145m In New Cash For Rare Diseases

Former Alexion execs and Rallybio co-founders Martin Mackay, Steve Uden and Jeffrey Fryer closed a series B venture capital round to take three candidates into the clinic and acquire additional programs.